A Cross-Species Transcriptomic Aging Clock

Key Takeaways

• Integrated >11,000 transcriptomes from mouse, rat, macaque, human.
• Identified universal aging genes CDKN1A and LGALS3 linked to mortality.
• Built multi-species clock predicting chronological age and time‑to‑death.
• Module-specific clocks reveal disease‑driven inflammation acceleration.
• Caloric restriction and Klotho deficiency target mitochondrial aging modules.

Pulse Analysis

The quest for a reliable biomarker of biological age has long been dominated by DNA‑methylation clocks, yet their applicability across species remains limited. By leveraging a massive, multi‑tissue transcriptomic dataset spanning four mammals, the new study delivers a cross‑species aging clock that captures the same molecular drift in both short‑lived rodents and long‑lived humans. This approach not only validates the conserved nature of ageing signatures but also expands the toolkit for researchers seeking a more nuanced readout of physiological decline.

Beyond a single aggregate age estimate, the authors decompose the transcriptomic signal into functional modules— inflammation, mitochondrial metabolism, chromatin remodeling, and extracellular matrix organization. These module‑specific clocks expose how distinct interventions reshape ageing trajectories: chronic diseases predominantly speed up inflammatory ageing, whereas caloric restriction and Klotho deficiency modulate mitochondrial and metabolic pathways. Such granularity mirrors the heterogeneity of age‑related pathologies and offers a roadmap for precision geroscience, where therapies can be matched to the ageing processes they most effectively counteract.

For biotech firms and pharmaceutical pipelines, a universal, interpretable aging clock promises to streamline preclinical validation. Interventions that demonstrate favorable shifts in the mouse‑derived modules can now be screened for comparable effects in human datasets before costly clinical trials. Moreover, the alignment with DNA‑methylation age acceleration strengthens confidence that transcriptomic and epigenetic clocks converge on shared ageing mechanisms. As the field moves toward combination therapies targeting multiple hallmarks, this modular framework will be instrumental in designing, monitoring, and optimizing interventions that aim to extend healthspan across the species spectrum.